XENVERZY
Live / Allowed — Fifth extension granted (statement of use) (as of 18 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Jul 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97500212
- Mark type
- Word mark
- Filed
- 12 Jul 2022
- Published for opposition
- 06 Jun 2023
- Attorney of record
- Ian W. Gillies
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases
Owner
- ZENTALIS PHARMACEUTICALS, INC., San Diego, CA, US
- ZENTALIS PHARMACEUTICALS, INC., San Diego, CA, US
Prosecution history
- 19 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2026 — SOU EXTENSION 5 GRANTED
- 26 Jan 2026 — SOU EXTENSION 5 FILED
- 16 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2025 — SOU EXTENSION 4 GRANTED
- 17 Jul 2025 — SOU EXTENSION 4 FILED
- 17 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jan 2025 — SOU EXTENSION 3 GRANTED
- 25 Jan 2025 — SOU EXTENSION 3 FILED
- 24 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2024 — SOU EXTENSION 2 GRANTED